MRNA Operating Income Growth
-1.44%TTM
Period ending:
MRNA TTM Operating Income YoY %%
2881.60%-1419.77%
2018-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
MRNA operating income growth history
Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 31 observations from Dec 31, 2018 to Jun 30, 2026.
| Period ending | Operating Income Growth |
|---|---|
| -1.436% | |
| 8.5009% | |
| 22.0786% | |
| -28.5926% | |
| 29.3851% | |
| 27.4372% | |
| 6.9356% | |
| -1.0507% | |
| -1,003.5088% | |
| -206.4636% | |
| -145% | |
| -120.1132% | |
| -96.7204% | |
| -70.3082% | |
| -29.1516% | |
| 74.091% | |
| 309.7076% | |
| 2,465.3366% | |
| 1,842.2662% | |
| 1,330.2294% | |
| 842.3251% | |
| 218.255% | |
| -39.5987% | |
| -8.7002% | |
| 1.8867% | |
| -12.2273% | |
| -32.2804% | |
| -88.4193% | |
| -84.5024% | |
| -78.8884% | |
| -53.4274% |
Compare operating income growth
All MRNA financial metrics · MRNA stock overview · How to interpret financial metrics
